Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Glaukos Corporation

GKOSNYSE
Healthcare
Medical - Devices
$119.02
$1.92(1.64%)
U.S. Market is Open • 12:27

Glaukos Corporation (GKOS) Stock Overview

Explore Glaukos Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.9B
P/E Ratio-36.34
EPS (TTM)$-1.49
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$60.03
3 Months$53.08
1 Year Target$132.00

GKOS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Glaukos Corporation (GKOS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $132.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -36.34 and a market capitalization of 6.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.84%
5-Day Change
11.93%
1-Month Change
-2.45%
3-Month Change
26.49%
6-Month Change
32.42%
Year-to-Date (YTD) Change
8.76%
1-Year Change
-23.47%
3-Year Change
139.79%
5-Year Change
26.88%
All-Time (Max) Change
285.72%

Contact Information

949 367 9600
229 Avenida Fabricante, Aliso Viejo, CA, 92672

Company Facts

9,950 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions